S. Korea getting 700000 vaccines doses from Israel as COVID cases surge – Reuters

A vial of the Pfizer vaccine against the coronavirus disease (COVID-19) is seen as medical staff are vaccinated at Sheba Medical Center in Ramat Gan, Israel December 19, 2020. REUTERS/Amir Cohen/File PhotoSEOUL/JERUSALEM, July 6 (Reuters) – South Korea said it will get 700,000 dosages of Pfizer-BioNTechs (PFE.N) coronavirus vaccine from Israel on loan this week, in an effort to speed up immunisation following a rise in infections around the capital Seoul.More than 1,000 COVID-19 cases were reported as of 6 p.m. on Tuesday, the highest because December and hundreds more than the 746 cases posted on Monday, Yonhap news firm reported, pointing out South Korean federal government health officials.Under the vaccine swap arrangement announced by both governments on Tuesday, South Korea will offer Israel back the very same number of shots, already on order from Pfizer, in September and October.South Korea has quickly distributed the COVID-19 vaccines it has, but has struggled to get enough dosages in a prompt manner as worldwide products are tight, particularly in Asia.Briefing press reporters in Jerusalem, Israeli Prime Minister Naftali Bennett stated the vaccines were being loaded aboard a plane within hours of the deals announcement on Tuesday, and that South Korean authorities would confirm their practicality.”After an excellent roll-out, Israel has actually administered both shots to around 55% of its population and turnout has plateaued.Korea Disease Control and Prevention Agency (KDCA) Director Jeong Eun-kyeong said the deal would enable South Korea to accelerate its vaccination strategies, consisting of providing shots to staff members in some sectors that have a high amount of contact with other people.Local authorities will choose who gets the vaccines, however she said top priority might be given to people such as street cleaners, delivery workers and retail employees.South Korean authorities said last week they were hoping to attain herd immunity earlier than the present November target by inoculating at least 70% of the population with a minimum of one vaccine dosage, mostly mRNA vaccines such as Pfizers.